Comparison of two flow cytometric methods for detection of aneuploidy in multiple myeloma:: Implications for investigation of residual disease

被引：0
|
作者：
Oelschlaegel, U [1 ]
Nowak, R [1 ]
Heider, T [1 ]
Naumann, R [1 ]
Bornhäuser, M [1 ]
Ehninger, G [1 ]
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
184
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [31] Progress in the application of minimal residual disease detection in multiple myeloma
    Zuo, Xiaojia
    Liu, Dingsheng
    JOURNAL OF HEMATOPATHOLOGY, 2021, 14 (02) : 97 - 107
  • [32] Flow cytometric minimal residual disease monitoring in patients with multiple myeloma undergoing autologous stem cell transplantation: A retrospective study
    Liu, Hong
    Yuan, Constance
    Heinerich, Jeremy
    Braylan, Raul
    Chang, Myron
    Wingard, John
    Moreb, Jan
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 306 - 314
  • [33] Comparison of Two Flow Cytometric Methods for Detection of Human Invariant Natural Killer T Cells (iNKT)
    Fereidouni, Mohammad
    Azad, Farahzad Jabbari
    Mahmoudi, Mahmoud
    Varasteh, Abdolreza
    Hosseini, Reza Farid
    IRANIAN JOURNAL OF IMMUNOLOGY, 2010, 7 (01) : 1 - 7
  • [34] Flow cytometric detection of aneuploid multiple myeloma clones in bone marrow aspirates.
    Kleine, HD
    Buthmann, U
    Freund, M
    BLOOD, 2001, 98 (11) : 299B - 299B
  • [35] CD99 expression in T-lineage ALL:: implications for flow cytometric detection of minimal residual disease
    Dworzak, MN
    Fröschl, G
    Printz, D
    De Zen, L
    Gaipa, G
    Ratei, R
    Basso, G
    Biondi, A
    Ludwig, WD
    Gadner, H
    LEUKEMIA, 2004, 18 (04) : 703 - 708
  • [36] CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease
    M N Dworzak
    G Fröschl
    D Printz
    L De Zen
    G Gaipa
    R Ratei
    G Basso
    A Biondi
    W-D Ludwig
    H Gadner
    Leukemia, 2004, 18 : 703 - 708
  • [37] Minimal Residual Disease Assessment in Multiple Myeloma Patients: Minimal Disease With Maximal Implications
    Charalampous, Charalampos
    Kourelis, Taxiarchis
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [38] High Sensitivity Detection of Residual Disease in Multiple Myeloma from Blood
    Murray, David
    Dispenzieri, Angela
    Dasari, Surendra
    Kohlhagen, Mindy
    Barnidge, David
    Mills, John
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E46 - E47
  • [39] Impact of minimal residual disease detection after treatment of multiple myeloma
    Szendrei Tamas
    Plander Mark
    Szabo Zsuzsanna
    Kereskai Laszlo
    Kajtar Bela
    Papp Gergely
    Ivanyi Janos Laszlo
    ORVOSI HETILAP, 2019, 160 (13) : 502 - 508
  • [40] Minimal residual disease detection in Ph plus acute lymphoblastic leukemia: Comparison between molecular and flow cytometric assays
    Jorgensen, JL
    Jones, DM
    Thomas, DA
    Cooper, DG
    Hai, S
    Huh, YO
    MODERN PATHOLOGY, 2005, 18 : 236A - 236A
12345